AI assistant
Sending…
Repare Therapeutics Inc. — Director's Dealing 2021
Sep 9, 2021
34365_dirs_2021-09-09_d6fb0341-3ae0-4962-90c2-0019019986ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2021-09-07
Reporting Person: Civik Thomas (Director)
More from Repare Therapeutics Inc.
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 30
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 28